AI-Driven Detection of Ovarian Cancer Surpasses Human Expert-Level Accuracy

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 9, 2025.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 9, 2025 -- Transformer-based neural network models exhibit strong generalization and surpass diagnostic performance of expert and nonexpert examiners for detecting ovarian cancer in ultrasound images, according to a study published online Jan. 2 in Nature Medicine.

Filip Christiansen, from the Karolinska Institutet in Stockholm, and colleagues developed and validated transformer-based neural network models using a comprehensive dataset of 17,119 ultrasound images from 3,652 patients across 20 centers in eight countries. For each center in turn, a model was trained using data from the remaining centers, using a leave-one-out cross-validation scheme.

The researchers found that across centers, ultrasound systems, histological diagnoses, and patient age groups, the models demonstrated robust performance, significantly outperforming expert and nonexpert examiners on all evaluated metrics (F1 score, sensitivity, specificity, accuracy, Cohen's kappa, Matthew's correlation coefficient, diagnostic odds ratio, and Youden's J statistic). Artificial intelligence (AI)-driven diagnostic support reduced referrals to experts by 63 percent in a retrospective triage simulation, while significantly surpassing the diagnostic performance of current practice.

"Our study demonstrates the potential of AI models in improving the accuracy and efficiency of ovarian cancer diagnosis," the authors write. "Our models demonstrated robust generalization and significantly outperformed both expert and nonexpert examiners on all evaluated metrics."

Several authors disclosed ties to medical technology companies, including Intelligyn; several authors have applied for a patent that is pending to Intelligyn.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-10 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords